22. NZW Europe

Peliminary Program as to 15th January 2014

Thursday, 23th January 2014 ESOP-Delegates-Meeting and Public Session
Time Title Speaker  
08:30-14:00 ESOP-Board meeting
14:00-15:00 Break
15:00-19:00 ESOP-Delegate meeting part I

Friday, 24th January 2014 ESOP-Delegates-Meeting and Public Session
Time Title Speaker  
08:00-12:30 ESOP-Delegate meeting part II
12:30-13:30 Break
14:00-18:00 ESOP meetings
13:30-15:00 ESOP “Contamination project” meeting
15.00-15.25 Break
  Chair: Dr. Vesna Pavlica
Zagreb, Croatia
15.25-15.45 New Place of Olanzapine in the Treatment of CINV Dr. Irena Netíková
Prague, Czech Republic
15.45-16.05 Medication Safety in Oncology Carole Chambers
Calgary, Canada
16.05-16.25 Patient Counseling – ESOP Project Mina Kovacevic
Ljubljana, Slovenia
16.25-16.45 Rational Prescribing - The Role of the Pharmacist and the Hospital Drug Formulary

Stavroula Theophanous-Kitiri

Strovolos, Cyprus
17:00-18:00 ESOP “Clean working group” meeting

Saturday, 25th January 2014 Lectures *
Time Title Speaker  
08.15 Welcome ISOPP
Welcome ADKA

Carole Chambers
Dr. Torsten Hoppe-Tichy

Calgary, Canada
Heidelberg, Germany

08.30-09.00 Predictive Molecular Pathology: A Prerequisite of Personalized Medicine
Prof. Dr. Manfred Dietel Berlin, Germany
09.00-09.30 Quo Vadis Regenerative Medicine? - of Stem Cells, Regeneration, Aging and Cancer

Prof. Dr. Mariusz Z. Ratajczak

Louisville, USA


Legal Framework for Bidding Procedures by Statutory Health Insurances in Oncology Pharmacy

Dr. Alexander Csaki

Düsseldorf, Germany


Take 29 Steps to develop an Integral Pharmaceutical Care Plan for Oncology Patients

Dr. Mirjam Crul
Kathleen Simons

Amsterdam & Tilburg
The Netherlands


Lunch Break





Michael Höckel, Kassel, Germany



Therapeutic Drug Monitoring of Imatinib in Patients with CML

Katarzyna Sobańska

Poznań, Poland


Selected Adverse Effects and Interactions of  low-molecular Kinase Inhibitors

Jürgen Barth

Gießen, Germany


Therapeutic Drug Monitoring in Cancer, are we missing a Trick?

Dr. Christophe Bardin

Paris, France


Miscibility of Infusions

Oliver Feth
Dr. Rainer Trittler

Stade, Germany
Freiburg, Germany







Dr. Reinhard Hanpft

Hamburg, Germany


Drug Shortages: how we have been coping. 
A 3-year detailed Overview from a Dutch University Medical Center.

Prof. Dr. Arno G. Vulto

Rotterdam, The Netherlands


Chemotherapy Drug Shortages in Europe: A Call to Action

Prof. Dr. Günther Wiedemann

Ravensburg, Germany


Who is afraid of Biosimilars?

Prof. Dr. Huub Schellekens
Prof. Dr. Arno G. Vulto

Utrecht, The Netherlands
Rotterdam, The Netherlands


Biosimilars und Good Pharmaceutical Practice in Inpatient Settings

Prof. Dr. Irene Krämer

Mainz, Germany

*simultaneously translated German-English

| Mehr

Impressum | AGB | Datenschutzerklärung